Estela Mota
Family Medicine · Weimar, TXNPI 1366736050
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,640 and has fallen 98.8% since, to $19 in 2025.
Across 103 payments — averaging $22.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$333
- Boehringer Ingelheim$296
- Lilly USA, LLC$284
- Novo Nordisk$281
- Amarin Pharma, Inc.$268
- Amgen$213
- plus $676 from 17 others
What the payments were for
- Food & beverage$2,344100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 11 | $333 |
| Boehringer Ingelheim | 6 | $296 |
| Lilly USA, LLC | 20 | $284 |
| Novo Nordisk | 13 | $281 |
| Amarin Pharma, Inc. | 7 | $268 |
| Amgen | 13 | $213 |
| Johnson & Johnson | 5 | $154 |
| Novartis | 4 | $143 |
| Astellas Pharma US Inc | 4 | $59 |
| Fisher & Paykel Healthcare Inc | 2 | $52 |
| AstraZeneca | 3 | $41 |
| Sanofi-aventis U.S. LLC | 3 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Genentech USA, Inc. | 1 | $23 |
| Exact Sciences | 1 | $19 |
| Bristol Myers Squibb | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Medicure Pharma Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,350 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 13 | $119 |
| Levothyroxine Sodium | 19 | $98 |
| Amlodipine Besylate | 20 | $78 |
| Doxycycline Hyclate | 12 | $75 |
| Pantoprazole Sodium | 11 | $70 |
| Trazodone Hcl | 14 | $40 |
| Cephalexin | 12 | $30 |
| Prednisone | 14 | $14 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Weimar
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.